Form 4 for TNGX Tango Therapeutics, Inc.
Accepted 2023-08-31 00:00:00 ET · period of report 2023-08-29 · accession 0000950170-23-045783 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-31 | 2023-08-29 | TNGX | Ketchum John B | Dir | A - Grant | $0.00 | +10.0K | 10.0K | New | $0 |
| D | 2023-08-31 | 2023-08-29 | TNGX | Ketchum John B | Dir | A - Grant | $0.00 | +60.0K | 60.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-08-29 | A | A | 10,000 | $0.00 | 10,000 | D | — | — | (F1) These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs will vest in three substantially equal annual installments on each of August 19, 2024, August 18, 2025 and August 17, 2026, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2023-08-29 | A | A | 60,000 | $0.00 | 60,000 | D | $7.19 · — to 2033-08-29 | 60,000 Common Stock | (F2) This option shall vest and become exercisable in 36 substantially equal monthly installments over a period of three years beginning on August 29, 2023, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date. |